Akers Biosciences Responds to Erroneous Earnings Call Press Release

NEW YORK--(BUSINESS WIRE)-- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company wholly unrelated to the Company. The press release was errantly issued by the newswire services under the Company’s name. The Company has not scheduled any earnings calls. The Company is investigating how this error occurred and reserves all rights to pursue all appropriate remedies upon learning more about the cause of this error.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005868/en/

Investor Relations: Hayden IR
Brett Mass, Managing Partner
Phone: (646) 536-7331
Email: [email protected]
www.haydenir.com

Source: Akers Biosciences, Inc.

You May Also Be Interested In

• SAP Q1 results fall short of Wall Street estimates as transformation kicks off
• Veritonic Doubles Down on Mobile Audio Attribution by Integrating with AppsFlyer
• The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance